Skip to content
Disclosery

Blankinship & Foster, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Blankinship & Foster, LLC on GSK, newest first. How the timeline and the estimate are built.

Blankinship & Foster, LLC held 4,832 GSK shares at 2026-06-30 per its 13F-HR filed 2026-07-31.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,832 shares
    Change vs previous 13F 0 shares

    0.05% of the 13F portfolio, value $253,293.

    13F-HR 0001580642-26-004739 filed by Blankinship & Foster, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,832 shares
    Change vs previous 13F 0 shares

    0.06% of the 13F portfolio, value $266,678.

    13F-HR 0001580642-26-002557 filed by Blankinship & Foster, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,832 shares
    Change vs previous 13F 0 shares

    0.05% of the 13F portfolio, value $236,961.

    13F-HR 0001580642-26-000390 filed by Blankinship & Foster, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,832 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $208,549.

    13F-HR 0001580642-25-006944 filed by Blankinship & Foster, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).